How the Senate megabill could backfire on conservatives

A provision in the Senate GOP's megabill, aimed at extending Trump's tax cuts, could inadvertently pressure conservative states like South Carolina to expand Medicaid. The bill proposes cuts to state-directed payments to hospitals, potentially costing South Carolina over $2.3 billion annually, according to the South Carolina Hospital Association. Facing budget shortfalls, states may be compelled to expand Medicaid to offset revenue losses, a move opposed by many Republicans; industry groups are lobbying key Republicans to remove the provision.

Analysis

A provision within the Senate GOP's proposed megabill presents a significant and paradoxical risk to the hospital sector, particularly in the 10 conservative states that have not expanded Medicaid. The bill aims to reduce state-directed payments for Medicaid services, with the South Carolina Hospital Association estimating a potential annual fiscal impact of over $2.3 billion for that state alone. The proposed mechanism involves a 10% annual reduction in these payments until they align with 100-110% of Medicare rates, a substantial cut from South Carolina's current level of over 200%. This creates a direct fiscal challenge for state budgets and hospital viability. The unintended consequence, as articulated by industry stakeholders, is that such a severe revenue loss could compel these states to adopt Medicaid expansion—a policy long opposed by Republicans—as the only viable means to offset the deficit, given the 90% federal cost coverage for new enrollees. The legislation's future is uncertain, facing internal GOP opposition from figures like Sen. Josh Hawley and intense lobbying efforts targeting key Republican lawmakers, highlighting the political volatility surrounding this specific provision.

Key Decisions for Investors

• Investors with exposure to hospital operators, particularly those with significant footprints in the 10 states that have not expanded Medicaid, should monitor the legislative progress of this bill as its passage would create a direct and material revenue headwind.
• Given the internal Republican opposition and intense industry lobbying, the provision faces a non-trivial risk of being amended or removed, so aggressively positioning for its negative impact may be premature.
• Should the bill pass in its current form, long-term investors should consider the increased probability of eventual Medicaid expansion in impacted states, which could create a future tailwind for patient volumes and revenues after an initial period of fiscal distress.